Kestra Medical Technologies, Ltd.
NASDAQ:KMTSMedical - Instruments & Supplies
-$0.07 today
- Market cap
- $1.69B
- Beta
- 0.83
- P/E (TTM)
- -6.9
- EPS (TTM)
- -$2.74
Volume 0.44M
Average 0.33M
KMTS Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Kestra Medical Technologies, Ltd.NASDAQ: KMTS
Other Non-current Liabilities · Q3 FY2026 · quarter ended Jan 2026
Other non-current liabilities falls 99.3% from a year ago
Other non-current liabilities stood at $1.89M at the end of Q3 FY2026, down 99.3% from a year earlier and down 95.7% from the prior quarter.
Context
- Other non-current liabilities amounted to 0.5% of total assets at the end of Q3 FY2026, down 259.3 pp from a year earlier.
- Other non-current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether other non-current liabilities keeps falling in the next quarterly balance sheet after a -99.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 8.24M USD
- Year-over-year change
- -95.4%
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-04-30 | 8.24M | -95.4% |
| FY2024 | 2024-04-30 | 177.19M | +73.4% |
| FY2023 | 2023-04-30 | 102.17M | — |
| FY2021 | 2021-04-30 | 360K | — |
| FY2020 | 2020-04-30 | 0 | — |
Other Non-current Liabilities vs competitors
How KMTS compares with its peers on the latest reported figures
- KMTS's Jan 2026 other non-current liabilities of $1.89M is the 2nd highest of the 3 companies compared; the peer median is $1.5M.
- Its year-over-year change of -99.3% is the lowest of 3, against a peer median of -29.3%.
- Other non-current liabilities amounts to 0.5% of total assets for KMTS, versus a peer median of 1.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $2.1M | +32.3% | +19.2% | 2.1% | |
| Jan 2026 | $1.89M | -99.3% | — | 0.5% | |
| Sep 2026 | $908K | -90.9% | -11.4% | 0.1% | |
| Peer median (excluding KMTS) | $1.5M | -29.3% | +3.9% | 1.1% | |
Competitors are the stored peer set for KMTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2020 Apr 2020 | FY2021 Apr 2021 | FY2023 Apr 2023 | FY2024 Apr 2024 | FY2025 Apr 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 5.76M | 24.34M | 14.81M | 8.25M | 237.6M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 2.11M | 2M | 8.08M |
| Inventory | 0 | 0 | 2.11M | 3.29M | 6.57M |
| Other Current Assets | 209K | 1.35M | (1.74M) | 419K | 1.69M |
| Total Current Assets | 6.17M | 26.2M | 18.42M | 14.91M | 255.33M |
| Property, Plant & Equipment (Net) | 1.13M | 3.08M | 16.72M | 28.39M | 36.91M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 580K | 1.24M | 3.51M | 2.65M | 3.51M |
| Total Non-current Assets | 1.71M | 4.33M | 20.23M | 31.04M | 40.42M |
| Total Assets | 7.87M | 30.52M | 38.66M | 45.95M | 295.74M |
| Account Payables | 1.83M | 1.7M | 6.16M | 23.89M | 23.96M |
| Short-term Debt | 0 | 0 | 20.45M | 0 | 187K |
| Tax Payables | 68K | 42K | 215K | 234K | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 4.67M | 6.19M | 8.49M |
| Total Current Liabilities | 4.02M | 6.61M | 36.74M | 32.97M | 37.98M |
| Long-term Debt | 0 | 20.24M | 17.32M | 42.54M | 41.1M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 360K | 102.17M | 177.19M | 8.24M |
| Total Non-current Liabilities | 0 | 22.15M | 119.5M | 222.36M | 52.36M |
| Total Liabilities | 4.02M | 28.76M | 156.23M | 255.33M | 90.34M |
| Common Stock | 1K | 1K | 1K | 1K | 51.35M |
| Retained Earnings | (135.98M) | (170.08M) | (312.32M) | (406.44M) | (520.25M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 3.86M | 1.77M | (117.58M) | (209.38M) | 205.41M |
| Total Debt | 452K | 22.85M | 39.13M | 45.17M | 44.31M |
| Net Debt | (5.3M) | (1.49M) | 24.32M | 36.92M | (193.28M) |
Kestra Medical Technologies, Ltd.
NASDAQ:KMTS
Intrinsic Alpha fair value
Locked
Current Price
$28.29
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.